
Danaher Corporation DHR
Annual report 2025
added 02-24-2026
Country |
|
IPO year |
- |
Industry |
Diagnostics research |
Stock Exchange |
NYSESPB |
Shares |
713 M |
Market Cap[1] |
$ 147 B |
EBITDA (LTM) |
$ 7.5 B |
P/E (LTM) |
28.17 |
P/S (LTM) |
5.53 |
EPS (LTM) |
7.43 |
Danaher Corporation is an American diversified conglomerate that manufactures and sells a wide range of industrial and scientific products. Founded in 1984, the company is now one of the largest corporations in the world. Product portfolio includes tools for medical and scientific research, industrial automation and quality control systems, water analysis equipment, and many other goods. The company offers its products in more than 125 countries around the world.
One of Danaher Corporation's key principles is continuous development and innovation. The company invests significant resources in scientific research and the development of new technologies, which has helped it to achieve leading positions in many industries. Also known for its management strategy, called the Danaher Business System (DBS). This system is based on Lean Manufacturing and Six Sigma principles and enables the company to effectively manage its processes and achieve high results.
Overall, it's a successful and innovative company that holds leading positions in many industries. Thanks to its management strategy and constant investments in scientific research, the company continues to grow and attract new customers from all over the world.
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
$ 118.03 | -2.76 % | $ 35.9 B | NYSE,SPB | ||
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Biodesix
BDSX
|
$ 15.41 | 0.49 % | $ 2 B | Nasdaq Global Market | ||
|
BioNano Genomics
BNGO
|
$ 1.14 | -0.95 % | $ 1.45 M | Nasdaq Capital Market,SPB | ||
|
Burning Rock Biotech Limited
BNR
|
$ 26.33 | 0.3 % | $ 279 M | Nasdaq Global Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Bioventus
BVS
|
$ 8.52 | -3.02 % | $ 534 M | Nasdaq Global Select Market | ||
|
Brainsway Ltd.
BWAY
|
$ 24.16 | 4.39 % | $ 99.4 M | Nasdaq Global Select Market | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
CareDx, Inc
CDNA
|
$ 18.89 | 0.69 % | $ 1.01 B | Nasdaq Global Market,SPB | ||
|
Celcuity
CELC
|
$ 107.94 | -3.37 % | $ 4.26 B | Nasdaq Global Select Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
Charles River Laboratories International
CRL
|
$ 177.86 | -0.35 % | $ 8.82 B | NYSE,SPB | ||
|
Castle Biosciences
CSTL
|
$ 29.24 | -1.12 % | $ 812 M | Nasdaq Global Market,SPB | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 212.36 | 0.21 % | $ 23.6 B | NYSE,SPB | ||
|
DarioHealth Corp.
DRIO
|
$ 11.3 | -5.6 % | $ 321 M | Nasdaq Capital Market | ||
|
DexCom
DXCM
|
$ 72.71 | -0.98 % | $ 28.4 B | Nasdaq Global Select Market,SPB | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Exact Sciences Corporation
EXAS
|
$ 103.32 | -0.06 % | $ 19.5 B | Nasdaq Capital Market,SPB | ||
|
Fulgent Genetics
FLGT
|
$ 14.61 | -4.7 % | $ 442 M | Nasdaq Global Market | ||
|
Co-Diagnostics
CODX
|
- | - | $ 79.8 M | Nasdaq Capital Market | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Guardant Health
GH
|
$ 91.72 | -2.33 % | $ 11.5 B | Nasdaq Global Select Market,SPB | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
ICON Public Limited Company
ICLR
|
$ 109.51 | 1.26 % | $ 9.03 B | Nasdaq Global Select Market,SPB | ||
|
IDEXX Laboratories
IDXX
|
$ 632.48 | -3.69 % | $ 50.9 B | Nasdaq Global Select Market,SPB | ||
|
Illumina
ILMN
|
$ 132.06 | -1.78 % | $ 21 B | Nasdaq Global Select Market,SPB | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
IQVIA Holdings
IQV
|
$ 174.73 | -2.28 % | $ 30 B | NYSE,SPB | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 285.7 | -1.18 % | $ 23.8 B | NYSE,SPB | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Lantheus Holdings
LNTH
|
$ 76.92 | 2.68 % | $ 5.19 B | Nasdaq Global Select Market,SPB | ||
|
Medpace Holdings
MEDP
|
$ 449.18 | -0.57 % | $ 13 B | Nasdaq Global Select Market,SPB | ||
|
Mettler-Toledo International
MTD
|
$ 1 331.55 | -2.57 % | $ 27.4 B | NYSE,SPB | ||
|
Myriad Genetics
MYGN
|
$ 4.98 | 8.03 % | $ 461 M | Nasdaq Global Select Market,SPB | ||
|
ENDRA Life Sciences
NDRA
|
$ 3.83 | -7.71 % | $ 2.06 M | Nasdaq Global Select Market | ||
|
NeoGenomics
NEO
|
$ 9.46 | -3.76 % | $ 1.21 B | Nasdaq Global Select Market,SPB | ||
|
Neogen Corporation
NEOG
|
$ 11.02 | -1.87 % | $ 2.39 B | Nasdaq Global Select Market,SPB | ||
|
National Research Corporation
NRC
|
$ 14.16 | 5.59 % | $ 347 M | Nasdaq Global Select Market | ||
|
Natera
NTRA
|
$ 199.25 | -4.23 % | $ 19.6 B | Nasdaq Global Select Market,SPB | ||
|
OPKO Health
OPK
|
$ 1.19 | -0.72 % | $ 826 M | Nasdaq Global Select Market | ||
|
Pacific Biosciences of California
PACB
|
$ 1.63 | -2.96 % | $ 489 M | Nasdaq Global Select Market,SPB | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.